Log in

NASDAQ:AVEOAVEO Pharmaceuticals SEC Filings & 10K Form

$4.79
-0.10 (-2.04 %)
(As of 07/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$4.71
Now: $4.79
$4.97
50-Day Range
$4.79
MA: $6.96
$9.99
52-Week Range
$2.23
Now: $4.79
$11.20
Volume594,300 shs
Average Volume544,639 shs
Market Capitalization$77.03 million
P/E Ratio7.85
Dividend YieldN/A
Beta1.62

SEC Filings

AVEO Pharmaceuticals (NASDAQ:AVEO) SEC Filings

DateFilerForm TypeView
07/06/2020
3:44 PM
AVEO Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2020
3:57 PM
AVEO Pharmaceuticals (Issuer)
YOUNG ROBERT C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2020
3:34 PM
AVEO Pharmaceuticals (Issuer)
Mayes, Gregory T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2020
3:34 PM
AVEO Pharmaceuticals (Issuer)
Spring Scarlett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2020
3:34 PM
AVEO Pharmaceuticals (Issuer)
BATE KENNETH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2020
3:31 PM
AVEO Pharmaceuticals (Issuer)
EVNIN ANTHONY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2020
4:22 PM
AVEO Pharmaceuticals (Subject)
Cormorant Asset Management, LP (Filed by)
Form SC 13G
06/29/2020
4:22 PM
AVEO Pharmaceuticals (Subject)
Cormorant Asset Management, LP (Filed by)
Form SC 13G
06/24/2020
4:03 PM
AVEO Pharmaceuticals (Subject)
Growth Equity Opportunities Fund IV, LLC (Filed by)
Form SC 13D/A
06/22/2020
4:31 PM
AVEO Pharmaceuticals (Issuer)
Sonsini Peter W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
4:30 PM
AVEO Pharmaceuticals (Issuer)
SANDELL SCOTT D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
4:29 PM
AVEO Pharmaceuticals (Issuer)
MAKOWER JOSHUA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
4:28 PM
AVEO Pharmaceuticals (Issuer)
Makhzoumi Mohamad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
4:27 PM
AVEO Pharmaceuticals (Issuer)
Florence Anthony A. Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
4:26 PM
AVEO Pharmaceuticals (Issuer)
BASKETT FOREST (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
4:26 PM
AVEO Pharmaceuticals (Issuer)
Growth Equity Opportunities Fund IV, LLC (Reporting)
NEA 15 GP, LLC (Reporting)
NEA Partners 15, L.P. (Reporting)
New Enterprise Associates 15, L.P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
11:10 AM
AVEO Pharmaceuticals (Subject)
Flynn James E (Filed by)
Form SC 13G
06/17/2020
4:14 PM
AVEO Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2020
4:10 PM
AVEO Pharmaceuticals (Filer)
Form 424B5
06/10/2020
4:19 PM
AVEO Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2020
7:30 AM
AVEO Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/27/2020
3:20 PM
AVEO Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/27/2020
3:17 PM
AVEO Pharmaceuticals (Filer)
Form DEFA14A
04/30/2020
6:05 AM
AVEO Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2020
5:08 AM
AVEO Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/28/2020
4:16 PM
AVEO Pharmaceuticals (Filer)
Form DEFA14A
04/28/2020
4:08 PM
AVEO Pharmaceuticals (Filer)
Form DEF 14A
04/23/2020
8:50 AM
AVEO Pharmaceuticals (Filer)
Form CT ORDER
04/23/2020
8:50 AM
AVEO Pharmaceuticals (Filer)
Form CT ORDER
03/16/2020
3:04 PM
AVEO Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/16/2020
3:03 PM
AVEO Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/19/2020
4:10 PM
AVEO Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2020
4:43 PM
AVEO Pharmaceuticals (Issuer)
BAILEY MICHAEL P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
4:42 PM
AVEO Pharmaceuticals (Issuer)
Rubin Karuna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
4:42 PM
AVEO Pharmaceuticals (Issuer)
Needle Michael N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2020
6:30 AM
AVEO Pharmaceuticals (Filer)
Form DEFA14A
01/24/2020
6:30 AM
AVEO Pharmaceuticals (Filer)
Form DEFA14A
01/08/2020
3:31 PM
AVEO Pharmaceuticals (Issuer)
Lucera Erick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2020
3:30 PM
AVEO Pharmaceuticals (Issuer)
Lucera Erick (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2020
5:41 AM
AVEO Pharmaceuticals (Filer)
Form DEF 14A
01/06/2020
3:50 PM
AVEO Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2019
3:45 PM
AVEO Pharmaceuticals (Filer)
Form PRE 14A
11/29/2019
8:25 AM
AVEO Pharmaceuticals (Filer)
Form CT ORDER
11/25/2019
3:30 PM
AVEO Pharmaceuticals (Issuer)
BAILEY MICHAEL P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2019
3:34 PM
AVEO Pharmaceuticals (Issuer)
Spring Scarlett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
6:15 AM
AVEO Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
6:14 AM
AVEO Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2019
6:00 AM
AVEO Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2019
8:10 AM
AVEO Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2019
6:24 AM
AVEO Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2019
4:22 PM
AVEO Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2019
3:10 PM
AVEO Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2019
8:42 AM
AVEO Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2019
4:26 PM
AVEO Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2019
3:04 PM
AVEO Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2019
6:05 AM
AVEO Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2019
5:15 AM
AVEO Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2019
7:02 AM
AVEO Pharmaceuticals (Issuer)
YOUNG ROBERT C (Reporting)
Form 4/A
06/13/2019
4:01 PM
AVEO Pharmaceuticals (Issuer)
BATE KENNETH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
4:00 PM
AVEO Pharmaceuticals (Issuer)
EVNIN ANTHONY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
4:00 PM
AVEO Pharmaceuticals (Issuer)
YOUNG ROBERT C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
4:10 PM
AVEO Pharmaceuticals (Filer)
Form DEFA14A
05/10/2019
12:40 PM
AVEO Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
05/09/2019
3:03 PM
AVEO Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2019
6:06 AM
AVEO Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2019
2:09 PM
AVEO Pharmaceuticals (Filer)
Form CT ORDER
04/30/2019
3:50 PM
AVEO Pharmaceuticals (Filer)
Form 10-K/A
04/30/2019
5:31 AM
AVEO Pharmaceuticals (Filer)
Form DEFA14A
04/30/2019
5:13 AM
AVEO Pharmaceuticals (Filer)
Form DEF 14A
04/19/2019
4:11 PM
AVEO Pharmaceuticals (Filer)
Form PRE 14A
04/17/2019
1:23 PM
AVEO Pharmaceuticals (Subject)
Growth Equity Opportunities Fund IV, LLC (Filed by)
Form SC 13D/A
04/08/2019
4:22 PM
AVEO Pharmaceuticals (Issuer)
Sonsini Peter W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2019
4:21 PM
AVEO Pharmaceuticals (Issuer)
SANDELL SCOTT D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2019
4:21 PM
AVEO Pharmaceuticals (Issuer)
MOTT DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2019
4:20 PM
AVEO Pharmaceuticals (Issuer)
MAKOWER JOSHUA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2019
4:20 PM
AVEO Pharmaceuticals (Issuer)
Makhzoumi Mohamad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2019
4:20 PM
AVEO Pharmaceuticals (Issuer)
Florence Anthony A. Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2019
4:19 PM
AVEO Pharmaceuticals (Issuer)
BASKETT FOREST (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2019
4:19 PM
AVEO Pharmaceuticals (Issuer)
BARRIS PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2019
4:18 PM
AVEO Pharmaceuticals (Issuer)
Growth Equity Opportunities Fund IV, LLC (Reporting)
NEA 15 GP, LLC (Reporting)
NEA Partners 15, L.P. (Reporting)
New Enterprise Associates 15, L.P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2019
3:46 PM
AVEO Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2019
3:41 PM
AVEO Pharmaceuticals (Filer)
Form 424B5
04/03/2019
5:06 AM
AVEO Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2019
3:31 PM
AVEO Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2019
3:04 PM
AVEO Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2019
3:03 PM
AVEO Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/01/2019
4:01 PM
AVEO Pharmaceuticals (Issuer)
Mayes, Gregory T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
3:46 PM
AVEO Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2019
3:35 PM
AVEO Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
9:17 AM
AVEO Pharmaceuticals (Subject)
Polar Capital LLP (Filed by)
Form SC 13G/A
02/08/2019
3:34 PM
AVEO Pharmaceuticals (Issuer)
Rubin Karuna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
3:32 PM
AVEO Pharmaceuticals (Issuer)
Needle Michael N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2019
4:26 PM
AVEO Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/21/2018
8:19 PM
AVEO Pharmaceuticals (Issuer)
Sonsini Peter W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
8:18 PM
AVEO Pharmaceuticals (Issuer)
SANDELL SCOTT D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
8:18 PM
AVEO Pharmaceuticals (Issuer)
MOTT DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
8:18 PM
AVEO Pharmaceuticals (Issuer)
MAKOWER JOSHUA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
8:17 PM
AVEO Pharmaceuticals (Issuer)
Makhzoumi Mohamad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
8:17 PM
AVEO Pharmaceuticals (Issuer)
Florence Anthony A. Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
8:16 PM
AVEO Pharmaceuticals (Issuer)
BASKETT FOREST (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 7/8/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.